After Hours: Wyeth, Elan slide; MetLife shares drop after outlook cut

Published on Wednesday 30 July 2008 - 00:23

Summary :
Elan Corp. and Wyeth shares drop sharply as investors take a closer look at details about a clinical study of an Alzheimer's treatment, while MetLife Inc. shares fall in the wake of the insurer's...
Read more

Information source

MarketWatch.com - Top Stories

http://www.marketwatch.com/news/default.asp?sit...

Website description
Stock Market Quotes, Business News and Financial News from the leading provider MarketWatch.com, wholly-owned subsidiary of Dow Jones & Company, Inc.

Articles published on this website : 0 / 7 days - 0 / 30 days

What is Alzheimer's? What is Alzheimer’s? Help could be on the way for Alzheimer's Elan, Wyeth sink on Alzheimer's study Elan, Wyeth shares fall on Alzheimer's study results

Other articles published on other websites on the same day

Elan Alzheimer's study disappoints http://www.pharmiweb.com/ New Alzheimer’s Drug Shows Success In Halting Disease Progression http://www.redorbit.com/ Health Winners & Losers: Elan http://www.thestreet.com/ First Ever Study on Alzheimer's Disease Treatment in Hispanics Presented at Major Medical Meeting http://www.hispanicbusiness.com/ Moms With Alzheimer's May Pass on Risk to Kids http://www.livescience.com/ Good News in Alzheimer's Awareness, Research http://chicagoist.com/ New drugs to fight Alzheimer’s http://howrah.org/ Being Single in Midlife Could Raise Risk for Dementia Later http://empowher.com/ Healthwatch for July 30, 2008 http://www.wvnstv.com/ Advances Made Against Alzheimer's Disease http://empowher.com/